Literature DB >> 11370618

Adjuvant therapy for pancreatic adenocarcinoma.

R A Abrams1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11370618     DOI: 10.1016/s1091-255x(01)80003-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  13 in total

1.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Authors:  C J Yeo; R A Abrams; L B Grochow; T A Sohn; S E Ord; R H Hruban; M L Zahurak; W C Dooley; J Coleman; P K Sauter; H A Pitt; K D Lillemoe; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

2.  Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications.

Authors:  R J Amdur; J T Parsons; W M Mendenhall; R R Million; S P Stringer; N J Cassisi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-01       Impact factor: 7.038

3.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

4.  Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

5.  Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

Authors:  R A Abrams; L B Grochow; A Chakravarthy; T A Sohn; M L Zahurak; T L Haulk; S Ord; R H Hruban; K D Lillemoe; H A Pitt; J L Cameron; C J Yeo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

6.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Authors:  J C Yang; A E Chang; A R Baker; W F Sindelar; D N Danforth; S L Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

7.  Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Authors:  A Chakravarthy; R A Abrams; C J Yeo; L T Korman; R C Donehower; R H Hruban; M L Zahurek; L B Grochow; S O'Reilly; H Hurwitz; E M Jaffee; K D Lillemoe; J L Cameron
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

8.  Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.

Authors:  M A Carducci; R A Abrams; C J Yeo; R H Hruban; M L Zahurak; J L Cameron; L B Grochow
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-04-01       Impact factor: 7.038

9.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

Authors:  J A Laurie; C G Moertel; T R Fleming; H S Wieand; J E Leigh; J Rubin; G W McCormack; J B Gerstner; J E Krook; J Malliard
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

10.  Adjuvant therapy for pancreatic cancer: back to the future.

Authors:  W F Regine; R A Abrams
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.